//Jeffrey A. Lieberman, MD
Jeffrey A. Lieberman, MD2018-03-09T14:17:35+00:00

Jeffrey A. Lieberman, MD

Jeffrey A. Lieberman, MD, is a member of the Editorial Advisory Board of Psychopharmacology Bulletin. Dr.Lieberman is the Lawrence C. Kolb Professor and Chairman, Department of Psychiatry, Columbia University College of Physicians and Surgeons; Director, New York State Psychiatric Institute; and Psychiatrist-in-Chief, Columbia University Medical Center of the NewYork-Presbyterian Hospital. Dr. Lieberman’s work has advanced the understanding of the natural history and pathophysiology of schizophrenia and the pharmacology and clinical effectiveness of antipsychotic drugs.

He is the recipient of many national and international honors and awards, including the Lieber Prize for Schizophrenia Research from the National Association for Research in Schizophrenia and Affective Disorders, the Adolph Meyer Award from the American Psychiatric Association, the Research Award from the National Alliance on Mental Illness, and the Neuroscience Award from the International College of Neuropsychopharmacology.

He is a member of numerous scientific organizations, including the National Academy of Sciences Institute of Medicine. He has authored more than 500 papers and articles published in the scientific literature and written and/or edited ten books on mental illness, psychopharmacology and psychiatry. In May 2012, Dr. Lieberman was installed as President-elect of the American Psychiatric Association (APA); he will serve as APA President from May 2013 to May 2014.

References

Jeffrey A. Lieberman, MD